DocGo (DCGO) Misses Q3 EPS by 16c, Beats on Revenue; Offers FY25 Revenue Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- AMD shares fall amid AI chip sector selloff
- JetBlue shares fall amid American results, fuel cost concerns
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- LKQ posts Q3 loss, replaces CEO amid Europe struggles
DocGo Announces Third Quarter 2025 Results
November 10, 2025 4:05 PM ESTCompany Achieves Record Volumes Across All Major Business Lines
Management to Host Conference Call and Webcast Today at 5:00 PM Eastern Time
NEW YORK--(BUSINESS WIRE)-- DocGo Inc. (Nasdaq: DCGO) (DocGo or the Company), a leading provider of technology-enabled mobile health and medical transportation services, today announced financial and operating results for the quarter ended September 30, 2025.
Third Quarter 2025 Financial Highlights
Total revenue for the third quarter of 2025 was $70.8 million, compared to $138.7 million in the third quarter of 2024. This decline was... More


